Title

Azithromycin for mild-to-moderate COVID-19.

Document Type

Response or Comment

Publication Date

10-1-2021

Journal

The Lancet Respiratory Medicine

Volume

9

Issue

10

Inclusive Pages

e99

DOI

10.1016/S2213-2600(21)00379-9

Keywords

Azithromycin; COVID-19; Humans; SARS-CoV-2

Peer Reviewed

1

Find in your library

Share

COinS